$5.265
-0.225 (-4.27%)At close
Price Predictions
Open in app to unlock longer-horizon forecasts.
UNCY Prediction & Forecast by Similar Chart Analysis
Alphio's UNCY stock price prediction model matches the current Unicycive Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $5.35 (+1.64%). The 1-week path is $4.91 (-6.80%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Should I Buy Unicycive Therapeutics Inc Stock?
Unicycive Therapeutics is currently not a strong buy due to recent FDA setbacks and price volatility. The stock is priced at $5.265, with an RSI of 39.161 indicating potential oversold conditions. However, the company has faced significant challenges, including a 37% drop in stock price after receiving a Complete Response Letter from the FDA, which highlights ongoing manufacturing issues. The forward P/E ratio is 3.4447, suggesting potential undervaluation, but the risks are substantial given the recent regulatory hurdles and the company's negative net income of $12.823 million in Q1 2026.
UNCY stock price ended at $5.27 on Friday, after losing -4.27%
Unicycive Therapeutics Inc (UNCY) last closed at $5.265, losing -4.27%. These facts feed the 1-day and 1-week UNCY price prediction above.
Forecast Drivers
Unicycive Therapeutics Inc (UNCY) forecast drivers combine similar chart patterns, seasonality, and moving averages.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Similar Chart Patterns
Stocks whose recent price path most closely matches UNCY, ranked by similarity.
Seasonality analysis for UNCY
Historically the probability of a positive August return for UNCY is 0.00%. February offers the highest probability of a positive month at 67.24%, while July is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-year price projections for UNCY
| Month | Min Price | Avg Price | Max Price | Potential ROI |
|---|---|---|---|---|
| Aug 2026 | $3.43 | $4.23 | $4.88 | -19.69% |
| Sep 2026 | $4.48 | $4.49 | $4.57 | -14.81% |
| Oct 2026 | $3.74 | $3.95 | $4.02 | -24.90% |
| Nov 2026 | $5.09 | $5.32 | $5.66 | +1.04% |
| Dec 2026 | $3.97 | $4.33 | $5.26 | -17.73% |
In 2026, Unicycive Therapeutics Inc (UNCY) is projected to range from $3.43 to $5.66.
Unicycive Therapeutics Inc 2026 monthly forecast
In Aug 2026, Unicycive Therapeutics Inc is projected to average $4.23, with a low of $3.43 and high of $4.88.
In Sep 2026, Unicycive Therapeutics Inc is projected to average $4.49, with a low of $4.48 and high of $4.57.
In Oct 2026, Unicycive Therapeutics Inc is projected to average $3.95, with a low of $3.74 and high of $4.02.
In Nov 2026, Unicycive Therapeutics Inc is projected to average $5.32, with a low of $5.09 and high of $5.66.
In Dec 2026, Unicycive Therapeutics Inc is projected to average $4.33, with a low of $3.97 and high of $5.26.
This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.